Dynavax Technologies (DVAX) Q1 2021 Earnings Call Transcript

·28-min read
Dynavax Technologies (DVAX) Q1 2021 Earnings Call Transcript

Joining me on the call today are Ryan Spencer, chief executive officer; Kelly MacDonald, chief financial officer; Robert Janssen, chief medical officer; and Donn Casale, senior vice president, commercial. Before I begin, I advise you that we will be making forward-looking statements today, including statements regarding HEPLISAV-B's commercial profile, its potential to become the standard of care and for universal recommendation.